By
Drug Target Review2025-01-06T08:00:51
Huntsman Cancer Institute researchers have identified a gene variant in Andean populations that could predict blood cancer treatment outcomes and potentially lead to targeted therapies.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2023-07-04T09:00:08
Sponsored by SB Drug Discovery
2023-04-12T15:28:08
Sponsored by nanoComposix
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
2023-03-23T14:46:21
Sponsored by Bio-Techne
2025-10-08T14:00:00
Sponsored by Eurofins Discovery
2025-09-18T12:00:00
Sponsored by Benchling
Site powered by Webvision Cloud